/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / ILiAD Biotechnologies

ILiAD Biotechnologies

United States

ILiAD Biotechnologies develops a vaccine for pertussis

Healthcare & Biotech

ILiAD Biotechnologies, based in United States, has 2 investors on file, among them BNP Paribas Développement and RA Capital. Its latest round on record is Series B, 10 Feb 2026. Its site was last checked 13 Nov 2026: site answers.

iliadbio.com

Funding

1 round on record
Latest roundSeries B10 Feb 2026
Since that round9 monthsno later round on record
Investors in its rounds42 with a VCinfo profile
Feb 2026Series BLed by RA Capital, with BNP Paribas Développement and 2 others

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

2 investors on file
InvestorEvidenceType
BNP Paribas DéveloppementPortfolio pageCorporate VC
RA CapitalPage + roundVenture capital

More from BNP Paribas Développement

30 companies on its checked portfolio

Its portfolio leans to Fintech (26%), Education (19%), Industrial & Manufacturing (11%).

GenoskinGenoskin keeps real, donor-consented human skin alive and immunocompet…HighlifeHighLife Medical develops a transcatheter solution for mitral valve re…Madison Energy InfrastructureMadison Energy Infrastructure develops and builds community infrastruc…PoppinsPoppins develops a medical application for children with dyslexiaSandboxAQSandboxAQ connects AI and Quantum techniques for business breakthrough…

See BNP Paribas Développement's full profile · Who invests alongside it

More from RA Capital

215 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (86%), Industrial & Manufacturing (4%), AI & Machine Learning (2%).

89 Bio, Inc. (Alumni)AN2 TherapeuticsAN2 Therapeutics develops boron-based medicines for various diseases, …ARS PharmaceuticalsARS Pharmaceuticals develops patient-friendly treatments, including a …AbcuroAbcuro develops therapies for autoimmune diseases and cancer.Aclaris TherapeuticsAclaris Therapeutics is a biopharmaceutical company that strives to tr…

See RA Capital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get ILiAD Biotechnologies and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when BNP Paribas Développement adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/iliadbio.com/investors

# also
GET /v1/companies/iliadbio.com
GET /v1/companies/iliadbio.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing